APA (7th ed.) Citation

HUBER, L., BIRK, R., KNUETTEL, M., ROTTER, N., ADERHOLD, C., SCHERL, C., . . . KRAMER, B. (2020). FGF Expression in HPV16-positive and -negative SCC After Treatment With Small-molecule Tyrosine Kinase Inhibitors and Everolimus. Anticancer research, 40(10), 5621-5630. https://doi.org/10.21873/anticanres.14575

Chicago Style (17th ed.) Citation

HUBER, LENA, RICHARD BIRK, MANUEL KNUETTEL, NICOLE ROTTER, CHRISTOPH ADERHOLD, CLAUDIA SCHERL, ANNE LAMMERT, FREDERIC JUNGBAUER, and BENEDIKT KRAMER. "FGF Expression in HPV16-positive and -negative SCC After Treatment With Small-molecule Tyrosine Kinase Inhibitors and Everolimus." Anticancer Research 40, no. 10 (2020): 5621-5630. https://doi.org/10.21873/anticanres.14575.

MLA (9th ed.) Citation

HUBER, LENA, et al. "FGF Expression in HPV16-positive and -negative SCC After Treatment With Small-molecule Tyrosine Kinase Inhibitors and Everolimus." Anticancer Research, vol. 40, no. 10, 2020, pp. 5621-5630, https://doi.org/10.21873/anticanres.14575.